RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ampio Pharmaceuticals Stock

Ampio Pharmaceuticals Employees 2024

Ampio Pharmaceuticals Employees

23

Ticker

AMPE

ISIN

US03209T1097

WKN

A1JGFU

In 2024, Ampio Pharmaceuticals employed 23 people, a 0% change from the 23 number of employees in the previous year.

Ampio Pharmaceuticals Aktienanalyse

What does Ampio Pharmaceuticals do?

Ampio Pharmaceuticals Inc is a biopharmaceutical company specialized in developing and marketing novel therapies for various diseases. The company was founded in 2010 and is headquartered in Englewood, Colorado. The history of Ampio Pharmaceuticals began with a goal: to realize the vision of developing innovative therapies that benefit patients. The founding idea focused on the development of a new therapy for osteoarthritis. Over time, however, the company diversified and specialized in the development of drugs for other areas such as diabetes, eye diseases, and pneumonia. Ampio Pharmaceuticals' business model is focused on cutting-edge technologies and scientific knowledge. The company employs an integrative approach that utilizes a variety of techniques, including cell-based therapies, gene therapies, and drug development. The company's core competencies lie in research, development, and marketing of innovative therapy options. Ampio Pharmaceuticals is divided into various business units. For example, the company is engaged in the development of drugs based on AMPio technologies. These compounds form the core of the therapy approaches and have already shown promising results in clinical trials. The company also emphasizes collaboration with partners to expedite the development of new therapy options. Another focus of Ampio Pharmaceuticals is the development of therapies for osteoarthritis. The company has developed a range of therapeutics targeting various aspects of the disease, such as anti-inflammatory agents and substances for joint cartilage regeneration. These therapies aim to alleviate the symptoms of osteoarthritis and provide patients with a higher quality of life. In addition to developing new therapy options, Ampio Pharmaceuticals also conducts clinical trials. These studies are designed to test the efficacy and safety of the developed drugs. Ampio Pharmaceuticals is committed to providing the highest standard of medical care by substantiating the safety and efficacy of their drugs through clinical trials. As a company specialized in drug development, Ampio Pharmaceuticals has launched a number of products on the market. These include Ampion, an injectable therapy for knee osteoarthritis, and Optina, an orally administered drug for the treatment of diabetes-related retinopathy. Overall, Ampio Pharmaceuticals is an innovative company specializing in the development of new therapy options. The company leverages modern technologies and scientific knowledge and aims to improve patients' lives through highly effective therapies. Ampio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Ampio Pharmaceuticals's Employee Base

Ampio Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Ampio Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Ampio Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Ampio Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Ampio Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Ampio Pharmaceuticals stock

How many employees does Ampio Pharmaceuticals have this year?

Ampio Pharmaceuticals has 23 undefined employees this year.

How many employees did Ampio Pharmaceuticals have compared to the previous year?

Compared to the previous year, Ampio Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Ampio Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Ampio Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Ampio Pharmaceuticals?

The number of employees can also have an impact on investors of Ampio Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Ampio Pharmaceuticals affect the company?

An increase in equity of Ampio Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Ampio Pharmaceuticals's equity affect the company?

A reduction in equity of Ampio Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Ampio Pharmaceuticals?

Some factors that can influence the equity of Ampio Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Ampio Pharmaceuticals so important for investors?

The equity of Ampio Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Ampio Pharmaceuticals influence the company?

The number of employees at Ampio Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Ampio Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Ampio Pharmaceuticals has changed by 0.

How many employees does Ampio Pharmaceuticals currently have?

Ampio Pharmaceuticals currently has 23 undefined employees.

Why is the number of employees important for investors of Ampio Pharmaceuticals?

The number of employees is important for investors of Ampio Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Ampio Pharmaceuticals take to change the number of employees?

To change the number of employees, Ampio Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Ampio Pharmaceuticals pay?

Over the past 12 months, Ampio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ampio Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Ampio Pharmaceuticals?

The current dividend yield of Ampio Pharmaceuticals is .

When does Ampio Pharmaceuticals pay dividends?

Ampio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ampio Pharmaceuticals?

Ampio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Ampio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ampio Pharmaceuticals located?

Ampio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ampio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ampio Pharmaceuticals from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did Ampio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Ampio Pharmaceuticals in the year 2023?

In the year 2023, Ampio Pharmaceuticals distributed 0 USD as dividends.

In which currency does Ampio Pharmaceuticals pay out the dividend?

The dividends of Ampio Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ampio Pharmaceuticals

Our stock analysis for Ampio Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ampio Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.